Toxins 2011, 3(10), 1233-1248; doi:10.3390/toxins3101233
Review

Structure-Based Design of Ricin Inhibitors

Department of Chemistry and Biochemistry, University of Texas, Austin, TX 78712, USA
* Author to whom correspondence should be addressed.
Received: 11 August 2011; in revised form: 21 September 2011 / Accepted: 26 September 2011 / Published: 13 October 2011
(This article belongs to the Special Issue Ricin Toxin)
PDF Full-text Download PDF Full-Text [3329 KB, uploaded 13 October 2011 10:24 CEST]
Abstract: Ricin is a potent cytotoxin easily purified in large quantities. It presents a significant public health concern due to its potential use as a bioterrorism agent. For this reason, extensive efforts have been underway to develop antidotes against this deadly poison. The catalytic A subunit of the heterodimeric toxin has been biochemically and structurally well characterized, and is an attractive target for structure-based drug design. Aided by computer docking simulations, several ricin toxin A chain (RTA) inhibitors have been identified; the most promising leads belonging to the pterin family. Development of these lead compounds into potent drug candidates is a challenging prospect for numerous reasons, including poor solubility of pterins, the large and highly polar secondary binding pocket of RTA, as well as the enzyme’s near perfect catalytic efficiency and tight binding affinity for its natural substrate, the eukaryotic ribosome. To date, the most potent RTA inhibitors developed using this approach are only modest inhibitors with apparent IC50 values in the 10−4 M range, leaving significant room for improvement. This review highlights the variety of techniques routinely employed in structure-based drug design projects, as well as the challenges faced in the design of RTA inhibitors.
Keywords: ricin; structure-based drug design; pteroic acid; RTA; pterin chemistry; ribosome inactivating protein; differential scanning fluorimetry; virtual drug screening; ICM

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Jasheway, K.; Pruet, J.; Anslyn, E.V.; Robertus, J.D. Structure-Based Design of Ricin Inhibitors. Toxins 2011, 3, 1233-1248.

AMA Style

Jasheway K, Pruet J, Anslyn EV, Robertus JD. Structure-Based Design of Ricin Inhibitors. Toxins. 2011; 3(10):1233-1248.

Chicago/Turabian Style

Jasheway, Karl; Pruet, Jeffrey; Anslyn, Eric V.; Robertus, Jon D. 2011. "Structure-Based Design of Ricin Inhibitors." Toxins 3, no. 10: 1233-1248.

Toxins EISSN 2072-6651 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert